Allergan Ahead of Earnings

Published on Wednesday, 01 February 2012 10:04 Written by Gerard Lerod

New York, February 1st (TradersHuddle.com) - Shares of Allergan Inc. ( NYSE:AGN) are trading higher by +1.25% ahead of its quarterly earnings release. Allergan, the maker of Botox anti-wrinkle therapy is expected to release its quarterly results on January 2^nd.

Wall Street Analysts consensus calls for a profit of $1 a share on $1.41 billion revenue.

Allergan estimates have a range of $0.04 a share. The high estimate calls for profit of $1.02 a share and the low estimate is calling for a profit of $0.98 a share, a year ago for the quarter the company reported $0.88 a share.

Allergan, Inc. ( NYSE:AGN) is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics and medical devices. The company develops products for the ophthalmic, neurological, medical aesthetics, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.

Other companies on the watch on this earnings event are Endo Pharmaceuticals Holdings Inc. NASDAQ:ENDP and GlaxoSmithKline plc NYSE:GSK.